These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
103 related items for PubMed ID: 21211358
1. [In vitro antimicrobial activity of piperacillin-sulbactam and other 7 antimicrobial agents against non-fermentative bacilli]. Zhuo C, Xiao SN, Qiu GX, Zhong NS. Zhonghua Nei Ke Za Zhi; 2010 Dec; 49(12):1015-9. PubMed ID: 21211358 [Abstract] [Full Text] [Related]
2. [Changes of antimicrobial resistance among nonfermenting gram-negative bacilli isolated from intensive care units from 1994 to 2001 in China]. Wang H, Chen MJ, China Nosocomial Pathogens Resistance Surveillance Study Group. Zhonghua Yi Xue Za Zhi; 2003 Mar 10; 83(5):385-90. PubMed ID: 12820914 [Abstract] [Full Text] [Related]
3. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005]. Yang QW, Xu YC, Chen MJ, Hu YJ, Ni YX, Sun JY, Yu YS, Kong HS, He L, Wu WY, Ye HF, Yang YM, Zhu LN, Guo SH, Ji P, Zhu ZH, Ren JK, Zhang LX, Sun ZY, Zhu XH, Tong MQ, Zhao WS, Mei YN, Liu Y, Zhang ZJ, Duan Q, Li D, Liu PP, Wang J, Han LX, Wang H, Xie XL. Zhonghua Yi Xue Za Zhi; 2007 Oct 23; 87(39):2753-8. PubMed ID: 18167265 [Abstract] [Full Text] [Related]
4. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam. Sader HS, Tosin I, Sejas L, Miranda E. Braz J Infect Dis; 2000 Feb 23; 4(1):22-8. PubMed ID: 10788842 [Abstract] [Full Text] [Related]
5. [Analysis of the distribution characteristics and drug resistance of non-fermenting bacterial infection in intensive care unit from 2009 to 2015]. Hao D, Hu Z, Liu X, Sun T, Wang T, Tian H, Wang X. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 May 23; 28(5):439-44. PubMed ID: 29920041 [Abstract] [Full Text] [Related]
6. ['In vitro' activity of different antimicrobial agents on Gram-negative nonfermentative bacilli, excluding Pseudomonas aeruginosa and Acinetobacter spp]. Vay CA, Almuzara MN, Rodríguez CH, Pugliese ML, Lorenzo Barba F, Mattera JC, Famiglietti AM. Rev Argent Microbiol; 2005 May 23; 37(1):34-45. PubMed ID: 15991478 [Abstract] [Full Text] [Related]
7. [Continuous surveillance of antimicrobial resistance among nosocomial gram-negative bacilli from intensive care units in China]. Chen MJ, Wang H, China Nosocomial Pathogens Resistance Surveillance Study Group. Zhonghua Yi Xue Za Zhi; 2003 Mar 10; 83(5):375-81. PubMed ID: 12820912 [Abstract] [Full Text] [Related]
8. [The reliability of using impenem, meropenem, cefoperazone-sulbactam and piperacillin-tazobactam to treat nosocomial Gram-negative bacterial infections with Monte Carlo simulation]. Xiao YH, Hu YJ. Zhonghua Nei Ke Za Zhi; 2017 Aug 01; 56(8):595-600. PubMed ID: 28789493 [Abstract] [Full Text] [Related]
9. [Antimicrobial resistance of Gram-negative bacilli isolated from 13 teaching hospitals across China]. Wang Q, Zhao CJ, Wang H, Yu YS, Zhu ZH, Chu YZ, Sun ZY, Hu ZD, Xu XL, Liao K, Xu YC, Zhang LY, Mei YN, Yang B, Ni YX. Zhonghua Yi Xue Za Zhi; 2013 May 14; 93(18):1388-96. PubMed ID: 24025503 [Abstract] [Full Text] [Related]
10. Comparison of antimicrobial resistance of Acinetobacter baumannii clinical isolates from Shanghai and Hong Kong. Ling TK, Ying CM, Lee CC, Liu ZK. Med Princ Pract; 2005 May 14; 14(5):338-41. PubMed ID: 16103700 [Abstract] [Full Text] [Related]
11. In vitro activities of piperacillin or cefoperazone alone and in combination with beta-lactamase inhibitors against gram-negative bacilli. Kuo HY, Wang FD, Yen YF, Lin ML, Liu CY. New Microbiol; 2009 Jan 14; 32(1):49-55. PubMed ID: 19382669 [Abstract] [Full Text] [Related]
13. [Evaluation of antibacterial activities of various antibiotics against glucose non-fermentative gram-negative rods other than Pseudomonas aeruginosa]. Kouda M, Fukuhara J, Takeuchi M, Ohgawara M, Matsuzaki H, Tohi H, Furuhata N, Maruyama M, Sasaki K, Sawabe E, Ikeda A, Suzuki T, Satoh H, Takahashi I, Kimura F, Nomura H, Ono E. Jpn J Antibiot; 1998 Jul 14; 51(7):475-87. PubMed ID: 9755431 [Abstract] [Full Text] [Related]
14. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria. Punpanich W, Tantichattanon W, Wongwatcharapaiboon S, Treeratweeraphong V. J Med Assoc Thai; 2008 Oct 14; 91 Suppl 3():S21-7. PubMed ID: 19255989 [Abstract] [Full Text] [Related]
15. In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from Intensive Care Units in Taiwan: SMART 2004 programme data. Hung MN, Hsueh PR, Chang HT, Lee WS, Chou MY, Chen IS, Wang JH, Lin CF, Shyr JM, Ko WC, Wu JJ, Liu YC, Huang WK, Teng LJ, Liu CY, Luh KT. Int J Antimicrob Agents; 2007 Feb 14; 29(2):145-52. PubMed ID: 16815690 [Abstract] [Full Text] [Related]
18. In vitro activities of colistin and ampicillin/sulbactam against Acinetobacter baumannii. Punpanich W, Munsrichoom A, Srisarang S, Treeratweeraphong V. J Med Assoc Thai; 2011 Aug 14; 94 Suppl 3():S95-100. PubMed ID: 22043760 [Abstract] [Full Text] [Related]
19. [In vitro antibacterial activity of cefoperazone-sulbactam]. Zhang Y, Zhang J, Zhou L. Zhonghua Nei Ke Za Zhi; 1995 Oct 14; 34(10):676-9. PubMed ID: 8731829 [Abstract] [Full Text] [Related]
20. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics]. Alişkan H, Colakoğlu S, Turunç T, Demiroğlu YZ, Erdoğan F, Akin S, Arslan H. Mikrobiyol Bul; 2008 Apr 14; 42(2):321-9. PubMed ID: 18697430 [Abstract] [Full Text] [Related] Page: [Next] [New Search]